follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

NeoStem subsidiary announces agreement with Sentien Biotechnologies

By

Back to Top Comments Email Print

Latest News

advertisement

NeoStem Inc., of Allendale, and its subsidiary, Progenitor Cell Therapy LLC, announced today the execution of a services agreement with Sentien
Biotechnologies Inc.

According to an announcement, under the agreement, PCT will provide services to support Sentien's development of its cell therapy product, including technology transfer, training and manufacturing. Terms were not disclosed.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top